Postbiotic Compound Shows Promise against Hard-to-Treat Heart Failure

Researchers at King's College London identified a new therapeutic mechanism for heart failure with preserved ejection fraction (HFpEF), a condition affecting nearly half of all heart failure patients. The natural postbiotic compound urolithin A may offer a new treatment avenue for this previously resistant condition.

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.